Known targets — ChEMBL curated mechanism
ACVR1ADORA1ADORA2AADORA2BADORA3ESR1ESR2FLT3GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSC1HRH1HTR7IDH1IDH2IRAK1JAK1JAK2JAK3MEN1OPRM1P2RX3PDE5ASCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASIGMAR1SLC6A2SYKTACR1TOP2ATYK2
The experimentally established mechanism targets of Citric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 known ✓ | O00255 | 3/20 | 0.41 |
| ▸ | HTR7 known ✓ | P34969 | 2/20 | 0.40 |
| ▸ | HRH1 known ✓ | P35367 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | SLC13A5 | Q86YT5 | 2/20 | 0.40 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.40 |
| ▸ | HTR1A | P08908 | 2/20 | 0.40 |
| ▸ | DRD2 | P14416 | 2/20 | 0.40 |
| ▸ | HTR2A | P28223 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycolic Acid SCHEMBL162066 | 0.85 | HDAC1 (0.47) | KDM4EMEN1KMT2AMAPTPOLB | |
| Succinic Acid SCHEMBL161277 | 0.82 | NOTUM (0.54) | ALDH1A1KDM4EMEN1KMT2AMAPT | |
| Malonic Acid SCHEMBL160931 | 0.82 | HDAC1 (0.50) | KDM4EMEN1KMT2AMAPTPOLB | |
| Adipic Acid SCHEMBL161400 | 0.79 | HTR7 (0.50) | KDM4EMEN1KMT2AMAPTPOLB | |
| SCHEMBL162670 | 0.78 | MAOA (0.46) | ALDH1A1KDM4EMEN1KMT2AHDAC1 | |
| Fumaric Acid SCHEMBL159723 | 0.77 | MEN1 (0.46) | KDM4EMEN1KMT2AMAPTPOLB | |
| Maleic Acid SCHEMBL161823 | 0.77 | MEN1 (0.46) | KDM4EMEN1KMT2AMAPTPOLB | |
| Iodide SCHEMBL162027 | 0.76 | MAOA (0.45) | ALDH1A1KDM4EMEN1KMT2AHDAC1 | |
| Bromide SCHEMBL161201 | 0.76 | MAOA (0.45) | ALDH1A1KDM4EHDAC1HDAC6DRD2 | |
| Alpha-Ketoglutaric Acid SCHEMBL162747 | 0.75 | NOTUM (0.48) | ALDH1A1KDM4EMEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012030953-A1 | 5-HT2C RECEPTOR AGONISTS IN THE TREATMENT OF DISORDERS AMELIORATED BY REDUCTION OF NOREPINEPHRINE LEVEL | ARENA PHARMACEUTICALS, INC. (US) | 2012-03-08 | — | — | WO | disclosed |